|
2004 Conference Publication Quantifying the use of the 'statin' antilipemic drugs in Nova Scotia, Canada and Queensland, AustraliaNissen, L. M., Cooke, C., Sketris, I. and Tett, S.E. (2004). Quantifying the use of the 'statin' antilipemic drugs in Nova Scotia, Canada and Queensland, Australia. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x |
|
2004 Conference Publication Perceptions of concordance with medicines: Focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitionersBajramovic Fejzic, J., Emmerton, L. M. and Tett, S. E. (2004). Perceptions of concordance with medicines: Focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. 13th International Social Pharmacy Workshop, Malta, 19-23 July, 2004. Malta: Malta College of Pharmacy Practice. |
|
2004 Conference Publication An argument for dose individualisation of sirolimus in renal transplant recipientsDansirikul, C., Duffull, S. B., Morris, R. and Tett, S.E. (2004). An argument for dose individualisation of sirolimus in renal transplant recipients. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.v31_i11_abs.x |
|
2004 Conference Publication Working with health professionals and consumers in tandem: What is the evidence?Tett, S.E (2004). Working with health professionals and consumers in tandem: What is the evidence?. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service. |
|
2004 Conference Publication Bayesian population pharmacokinetic analysis of sirolimusDansirikul, C., Friberg, L. E., Duffull, S. B., Morris, R. and Tett, S.E. (2004). Bayesian population pharmacokinetic analysis of sirolimus. Population Approach Group in Europe - Thirteenth Meeting (PAGE), Uppsala University, Sweden, 17-18 June 2004. Sweden: Uppsala University. |
|
2004 Conference Publication Is cystatin-C a marker of renal function?Roos, J. F., Kirkpatrick, C. M. J. and Tett, S. E. (2004). Is cystatin-C a marker of renal function?. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x |
|
2004 Conference Publication Sample medication: What do Australian general practitioners think?Nissen, L. M., Hall, K. H. and Tett, S. E. (2004). Sample medication: What do Australian general practitioners think?. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service. |
|
2004 Conference Publication How is leflunomide prescribed and used in Australia? Analysis of prescribing, usage and adverse effect reportingChan, V. and Tett, S. E. (2004). How is leflunomide prescribed and used in Australia? Analysis of prescribing, usage and adverse effect reporting. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service. |
|
2004 Conference Publication Pharmacokinetics and pharmacodynamics of mycophenolic acid and its glucuronide early after renal transplantationTett, S. E., Atcheson, B. A., Taylor, P. J., Johnson, D. W., Mudge, D. W. and Pillans, P. I. (2004). Pharmacokinetics and pharmacodynamics of mycophenolic acid and its glucuronide early after renal transplantation. 8th World Conference on Clinical Pharmacology & Therapeutics 2004, Brisbane, Australia, 1-6 August, 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x |
|
2004 Conference Publication Do prescription medicine samples influence prescribing? Issues in Australian general practiceHall, K. H., Tett, S. E. and Nissen, L. M. (2004). Do prescription medicine samples influence prescribing? Issues in Australian general practice. Annual Conference of the APSA, 2004, Melbourne, Vic, Australia, 4-7 December, 2004. Mount Waverley, Victoria: Australasian Pharmaceutical Science Association. |
|
2004 Conference Publication Population pharmacokinetic and pharmacodynamic analysis of leflunomide in rheumatoid arthritisChan, V., Charles, B. G. and Tett, S. E. (2004). Population pharmacokinetic and pharmacodynamic analysis of leflunomide in rheumatoid arthritis. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x |
|
2004 Conference Publication Cross country comparisons of drug utilisation: Experiences with an Australian and Canadian 'statin' comparisonSketris, I., Cooke, C., Nissen, L. M. and Tett, S.E (2004). Cross country comparisons of drug utilisation: Experiences with an Australian and Canadian 'statin' comparison. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service. |
|
2003 Conference Publication Can telepharmacy provide pharmacy services in the bush?Nissen, L. M. and Tett, S.E. (2003). Can telepharmacy provide pharmacy services in the bush?. 3rd International Conference on Successes and Failures in Telehealth 2003, Brisbane, 25-26 August, 2003. London: Royal Society of Medicine Press. doi: 10.1258/135763303322596228 |
|
2003 Conference Publication Detecting drug interactions associated with tacrolimusStaatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S.E. (2003). Detecting drug interactions associated with tacrolimus. 5th Annual PAWS & PAGANZ Scientific Meeting, Sydney, Aust., 19-21 Feb. 2003. Sydney: |
|
2003 Conference Publication Five year trends in HMG co-A reductase inhibitor use in Nova Scotia, Canada and Queensland, AustraliaCooke, C., Tett, S.E and Sketris, I. (2003). Five year trends in HMG co-A reductase inhibitor use in Nova Scotia, Canada and Queensland, Australia. Annual Conference of the Canadian Association for Population Therapeutics 2003, Quebec, 30 Mar. - 1 Apr. 2003. Canada: Pulsus. |
|
2003 Conference Publication Analysis of free mycophenolic acid and its glucuronide in human blood samplesAtcheson, B., Taylor, P. J. and Tett, S. E. (2003). Analysis of free mycophenolic acid and its glucuronide in human blood samples. IATDMCT Congress, Basel, Switzerland, September 2003. New York , U. S.: |
|
2003 Conference Publication Pharmacodynamic investigations of tacrolimus in liver transplantationStaatz, C. E., Dansirikul, C., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S. E. (2003). Pharmacodynamic investigations of tacrolimus in liver transplantation. TSANZ 21st Annual Scientific Meeting, Canberra, 9-11 April 2003. Canberra: TSANZ. doi: 10.1046/j.1440-1711.2003.00812.x |
|
2003 Conference Publication Limited sampling strategies for monitoring tacrolimus in liver transplant recipientsDansirikul, C., Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S.E. (2003). Limited sampling strategies for monitoring tacrolimus in liver transplant recipients. 5th Annual PAWS & PAGANZ Scientific Meeting, Sydney, Aust., 19-21 Feb. 2003. Sydney: |
|
2003 Conference Publication Implementing a community pharmacy care integration project in rural AustraliaNissen, L. M. and Tett, S. E. (2003). Implementing a community pharmacy care integration project in rural Australia. Annual Conference of the Canadian Association for Population Therapeutics 2003, Quebec, 30 March - 1 April 2003. Canada: Pulsus. |
|
2003 Conference Publication Pharmacodynamics of tacrolimus in pediatric liver transplantationStaatz, C. E., TaylorPJ, LynchSV, TettSE, SSoldin and FSjoeqvist (2003). Pharmacodynamics of tacrolimus in pediatric liver transplantation. 8th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Basel, Switzerland, 7-11 September, 2003. New York: Lippincott-Raven. |
